Latest News and Press Releases
Want to stay updated on the latest news?
-
Continues to Explore Opportunities for Use of the Compound as a Potential Treatment for COVID-19 NEW YORK, NY, June 23, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading...
-
Revenue of $17 million and EPS of ($0.21) due to COVID-19 impactAchieved major milestone with launch of comprehensive COVID-19 program for virus screening and antibody testing NEW YORK, June 08,...
-
NEW YORK, NY, June 03, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) a leading biosciences and diagnostics company, today announced that it will release its third quarter 2020 financial...
-
Second Product Offering to Expand Disease Management within Enzo’s Comprehensive COVID-19 Program Enzo’s ELISA Kit for SARS-CoV-2 IgG Antibody Demonstrates High Specificity and High Sensitivity...
-
NEW YORK, NY, May 12, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,626,170...
-
NEW YORK, NY, April 29, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,624,863...